Boston Scientific (NYSE:BSX)
SEC filing history & article coverage
Transparent by design.
Announcments by Boston Scientific (NYSE:BSX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation; Other Events
Boston Scientific prices $3.0 billion and €4.25 billion debt offerings to help fund Penumbra acquisition
Departure/Election of Directors or Officers; Compensatory Arrangements; Other Events
Boston Scientific approves 2027 incentive plans and appoints David Wichmann as lead independent director